Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer
Part of paid clinical trials in Casa Grande, Arizona.
- Sponsor
- Eli Lilly and Company
- Study ID
- NCT01109524
- Phase
- PHASE2
- Status
- Completed
Conditions
- Cancer of the Lung
- Carcinoma
- Lung Neoplasms
- Non-Small-Cell Lung Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cetuximab — DRUGVial, Intravenous, 400mg/m², week 1, then 250mg/m², Weekly, Until Progressive Disease (PD)/ Toxicity/Pt-PI Decision
- Cisplatin — DRUGVial, Intravenous, 80mg/m², Day 1 of each 21 day cycle, Maximum 6 cycles
- Vinorelbine — DRUGVial, Intravenous, 25 mg/m², Day 1 and 8 of each 21 day cycle, Maximum 6 cycles
Study Details
The purpose of the study is to determine if U.S. manufactured Cetuximab can be safely used for the treatment of Non-Small Cell Lung Cancer in combination with Cisplatin and Vinorelbine.
Key Dates
- Start date
- Jul 31, 2010
- Status verified
- Nov 2015
- Primary completion
- Sep 30, 2012
- Completion
- Sep 30, 2012
Study Design
- Enrollment
- 72 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Cetuximab + Cisplatin + Vinorelbine
Primary Outcome Measure
Number of Participants With Any Treatment-emergent Adverse Events (AEs), Serious Adverse Events (SAEs), Deaths, and AEs Leading to Discontinuation of at Least One Study Drug, - Treated Population [ Time Frame: Day 1 up to 30 days after last dose ]
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Donald W. Hill M.D., P.C. | Casa Grande | Arizona | 85122 | - |
| Beverly Hills Cancer Center | Beverly Hills | California | 90211 | - |
| Cancer Care Institute | Los Angeles | California | 90036 | - |
| Northern California Hematology & Oncology | Oakland | California | 94609 | - |
| Sharp Clinical Oncology Research | San Diego | California | 92123 | - |
| Broward Oncology Associates, P.A. | Fort Lauderdale | Florida | 33308 | - |
| Elite Research Institute | Miami | Florida | 33125 | - |
| Edward H. Kaplan, MD & Associates | Skokie | Illinois | 60076 | - |
| Fairview Southdale Medical Oncology Clinic | Edina | Minnesota | 55435 | - |
| Mid Dakota Clinic, Pc | Bismarck | North Dakota | 58501 | - |
| Temple University Hospital | Philadelphia | Pennsylvania | 19140 | - |
| University Medical Center | Lubbock | Texas | 79415 | - |
| Columbia Basin Hematology and Oncology | Kennewick | Washington | 99336 | - |
Find similar trials in Casa Grande, AZ
By condition
By specialty
Related Studies
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and NeckPHASE2 · Recruiting · Alain Algazi · San Francisco, California
- Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067PHASE1/PHASE2 · Recruiting · Simcha IL-18, Inc. · Scottsdale, Arizona
- Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor TherapyPHASE2 · Recruiting · NATCO Pharma Ltd. · Fullerton, California